TorHoerman Law is actively accepting claims for the Depo-Provera Lawsuit.
Defendants
Pfizer, Inc.
Pharmacia & Upjohn Co. LLC
Pharmacia LLC
Vitaris Inc.
Greenstone LLC
Prasco LLC (Prasco Labs)
Injuries named in lawsuit
Intracranial meningiomas
Spinal cord meningiomas
Inoperable brain tumors
Need for brain surgery
Tumor recurrence
Ongoing medical monitoring
Permanent neurological damage post-surgery
You may qualify to file a claim if...
You received at least 2 Depo-Provera injections after 1992 and were diagnosed with intracranial meningioma confirmed by imaging (MRI or CT scan).
You used Depo-Provera for over one year.
You had no brain tumor history before Depo-Provera use, and medical records show the tumor developed after starting injections (even if diagnosed months or years later).
Most Recent Updates
Our Depo-Provera Lawyers are accepting new clients for this lawsuit.
How to File a Depo-Provera Lawsuit: Step-By-Step Guide
This page explains how to file a Depo-Provera lawsuit, who may qualify, what records may be needed, and what happens after requesting a case review.
It is intended for individuals who received Depo-Provera or another injectable medroxyprogesterone acetate product and were later diagnosed with an intracranial or spinal meningioma, as well as family members seeking information on their behalf.
TorHoerman Law can help locate relevant medical and injection records, evaluate filing deadlines, and determine whether a claim may move forward.
Contact us today for a free consultation or use the chat feature on this page to get in touch with our team of Depo Provera lawyers.
See If You Qualify to File a Depo-Provera Lawsuit Today
The Depo-Provera lawsuits involve women who received repeated injections and were later diagnosed with a meningioma affecting the brain or spinal cord.
Plaintiffs allege that Pfizer and related companies failed to warn patients and prescribing clinicians about the tumor risk associated with long-term use of injectable medroxyprogesterone acetate.
The federal cases are coordinated through the Depo Provera multidistrict litigation in the Northern District of Florida.
In June 2026, plaintiffs’ leadership and certain defendants reached an agreement that may allow eligible federal claimants to resolve their cases through a Depo Provera settlement program.
The agreement will not resolve every lawsuit, and its eligibility requirements and payment terms have not been publicly disclosed.
A Depo shot claim requires more than submitting a registration form.
Attorneys must review the claimant’s injection history, diagnosis, treatment, medical records, applicable filing deadline, and any requirements established by the settlement program.
Individuals do not need to possess every medical or prescription record before contacting a law firm, because attorneys may be able to obtain missing documentation from healthcare providers, clinics, pharmacies, and insurers.
This page explains the steps to file a Depo-Provera lawsuit, the preliminary qualification criteria, the evidence that may support a claim, and what happens after a prospective client requests a case review.
Submitting your information begins an evaluation and does not automatically file a lawsuit, confirm settlement eligibility, or create an attorney-client relationship.
TorHoerman Law is reviewing claims from individuals who received at least two Depo-Provera injections and were later diagnosed with an intracranial or spinal meningioma.
Our attorneys can evaluate your records, identify potential defendants, review filing deadlines, and explain the legal options that may apply to your case.
Eligibility Requirements for the Depo Provera Lawsuit
Women may qualify for the Depo shot MDL if they received at least two Depo-Provera injections and were later diagnosed with a meningioma affecting the brain or spinal cord.
Medical documentation must prove both product use and injury, including records confirming the dates of the injections and the diagnosis of a qualifying tumor.
Potential eligibility requirements include:
Receiving Depo Provera injections on at least two occasions
A confirmed diagnosis of an intracranial or spinal meningioma
Medical, insurance, pharmacy, or billing records proving Depo-Provera use
Imaging, pathology, surgical, or treatment records confirming the diagnosis
Filing within the applicable statute of limitations, which is generally two to three years after diagnosis in most states
Submission of proof of use and injury within 120 days after filing, as required under current MDL procedures
There is no general sign-up form that automatically enrolls someone in the Depo-Provera litigation.
Participation typically begins by contacting and hiring a personal injury or mass tort lawyer who can review the records, determine whether the claim meets current criteria, and file the case in the appropriate court.
The lawsuits allege that repeated exposure to Depo-Provera increased the risk of brain and spinal cord tumors and that patients should have received an earlier warning.
The FDA added a meningioma warning to the Depo-Provera label in December 2025, while Pfizer denies wrongdoing and maintains that it complied with applicable FDA requirements.
Depo-Provera Lawsuit Sign-Up: Steps to Take and What to Do
There is no public form that automatically enrolls someone in the Depo shot lawsuit.
The process begins by contacting a law firm that handles pharmaceutical litigation and providing basic information about Depo-Provera use, the number of injections received, and any intracranial or spinal meningioma diagnosis.
An attorney will review the claimant’s injection history, diagnosis date, treatment, medical records, and applicable filing deadline.
The federal litigation involves allegations that the birth control injection exposed users to undisclosed health risks, including the development of one or more meningiomas.
Pfizer maintains that Depo-Provera is safe and effective and denies plaintiffs’ allegations.
Relevant records may include:
Injection, prescription, insurance, or billing records confirming Depo-Provera use
MRI or CT reports confirming a meningioma
Pathology and surgical records
Radiation, neurological, and follow-up treatment records
Employment records documenting lost income or work limitations
Prospective claimants do not need to locate every record before requesting a case review.
A law firm may obtain missing documents from healthcare providers, clinics, pharmacies, and insurance companies after receiving the necessary authorizations.
If the firm accepts the claim, an attorney may file an individual complaint that complies with the federal MDL’s direct-filing and pleading requirements.
Counsel must also submit the required proof of Depo-Provera use and meningioma injury and respond to any identified deficiencies within the deadlines established by the court.
Submitting information does not automatically file a lawsuit, confirm eligibility, or enroll the claimant in the June 2026 resolution process.
Representation begins only after the firm accepts the case and the claimant signs an attorney-client agreement.
Step 1: Initial Consultation with a Depo-Provera Lawsuit Attorney
The process begins with a free consultation with Depo Provera lawsuit lawyers who can review the basic facts of a potential claim.
During the evaluation, the claimant or a family member may be asked when she was prescribed Depo Provera, how many injections she received, when she was diagnosed, and whether the diagnosis involved an intracranial or spinal meningioma.
Eligibility assessments focus heavily on the timing between Depo-Provera use and the meningioma diagnosis.
Attorneys may also ask about surgery, radiation, neurological symptoms, available medical records, and whether another law firm already represents the claim.
Individuals may complete the chat feature quiz on this page for quick preliminary feedback about a potential Depo Provera meningioma lawsuit.
The online review does not confirm eligibility or automatically file a case in the federal Depo Provera MDL.
A final decision requires attorney review of the claimant’s medical history, injection records, diagnosis, and applicable filing deadline.
Step 2: Gathering Medical Records and Evidence
The next step is collecting medical records that confirm both use of the birth control shot and the meningioma diagnosis.
Relevant documents may include records identifying brand name Depo Provera or another medroxyprogesterone acetate product, the dates and number of injections, diagnostic imaging, pathology reports, surgical records, and follow-up treatment.
Pharmacy histories, insurance claims, billing statements, and records from the clinic that administered the injections may help establish product use when older medical files are incomplete.
Claimants do not need to locate every document before contacting an attorney, because the law firm may request missing records after receiving the required authorizations.
Attorneys will organize the evidence, identify gaps, and determine whether the records support the exposure and injury requirements for the claim.
They may also work with qualified medical experts to evaluate causation, treatment, prognosis, and the long-term effects of the tumor.
Step 3: Filing the Depo-Provera Lawsuit
After the law firm accepts the case and reviews the available records, an attorney will determine the proper court and identify the Depo Provera manufacturers or distributors that may be named as defendants.
The attorney will then prepare an individual complaint describing the claimant’s Depo-Provera use, meningioma diagnosis, injuries, damages, and legal allegations.
Qualifying intracranial meningioma claims may be filed directly in the Northern District of Florida for coordinated proceedings in the Depo shot litigation.
Each plaintiff retains an individual lawsuit, and the complaint must identify the federal district where the case otherwise would have been filed.
After filing, the legal team must complete the MDL’s procedural requirements.
These include serving the complaint, submitting documentary proof of product use and meningioma injury, and completing the required questionnaire within 120 days of filing or transfer into the MDL.
The attorneys manage court filings, deadlines, deficiency notices, and communications with defense counsel while keeping the client informed about significant developments.
Filing a complaint does not guarantee that the claim will qualify for a settlement or result in compensation.
Step 4: Ongoing Legal Representation and Support
After a lawsuit is filed, attorneys continue to manage court deadlines, required proof of use and injury, record submissions, deficiency notices, discovery, and communications with the defendants.
Clients may be asked to provide additional medical or insurance information as their claims are reviewed.
In June 2026, plaintiffs’ leadership announced a Depo shot settlement intended to resolve a majority of the federal and New York claims.
A formal Master Settlement Agreement was signed on July 21, 2026, and the parties estimate that approximately 80% of federal MDL plaintiffs may satisfy its confidential eligibility requirements.
As of July 27, 2026, the federal docket included 6,289 total actions.
Attorneys will determine whether an individual client may participate, explain the settlement process, and submit the required registration and claim documentation.
The current schedule anticipates settlement registration concluding in November 2026, with payments potentially beginning during the first quarter of 2027.
The Depo Provera MDL continues to address claims involving plaintiffs who are ineligible for the agreement or choose not to participate.
Those cases may proceed through expert challenges, legal motions, additional discovery, settlement negotiations, or trial preparation.
Participation in the settlement process does not guarantee eligibility, a specific payment, or recovery of compensation.
TorHoerman Law manages the legal and administrative work involved in pursuing a Depo-Provera claim so clients can focus on their health and treatment.
Our attorneys and legal staff help obtain injection and medical records, review evidence, prepare court filings, satisfy MDL requirements, and evaluate potential eligibility for the current settlement process.
Clients may be asked to sign record authorizations, answer follow-up questions, review important documents, or provide additional information as the case develops.
Our team explains what is needed, tracks applicable deadlines, and communicates significant litigation or settlement developments.
We also handle communications with defendants and their attorneys, respond to court requirements, and assess the available resolution options for each client.
No result is guaranteed, but TorHoerman Law works to present each claim accurately and pursue the compensation supported by the client’s injuries and documented losses.
Depo-Provera is a contraceptive injection containing medroxyprogesterone acetate, a synthetic hormone used to prevent pregnancy.
Research has found that women who used the Depo Provera contraceptive injection for more than one year had approximately 5.6 times higher odds of developing meningioma brain tumors.
Meningiomas arise from the membranes surrounding the brain and spinal cord and account for approximately 30% to 40% of primary brain tumors.
Although they are typically nonmalignant, a brain or spinal tumor can cause seizures, vision loss, cognitive impairment, chronic headaches, and other serious neurological complications.
Women are filing lawsuits alleging that Pfizer failed to provide clear warnings about the meningioma risk associated with long-term Depo-Provera use.
Drug manufacturers are responsible for providing adequate information about known or reasonably discoverable risks, but Pfizer disputes liability and maintains that it complied with applicable regulatory requirements.
The ongoing cases are coordinated in multidistrict litigation in federal court.
Individuals seeking to sue Depo Provera manufacturers must provide evidence of their injection history, meningioma diagnosis, treatment, and resulting damages.
TorHoerman Law is reviewing claims from women who received repeated Depo-Provera injections and were later diagnosed with an intracranial or spinal meningioma.
Contact our attorneys for a free case review, or use the chat feature to complete a preliminary eligibility assessment.
Depo Provera Lawsuit Settlement Amounts: Projections and Estimates
Estimated settlement amounts in Depo Provera cases may range from approximately $150,000 to more than $1 million, depending on the severity of the claimant’s meningioma and resulting losses.
Average settlements in other meningioma cases have exceeded $800,000, although those outcomes do not establish an average payment for Depo Provera users.
Jury verdicts in comparable cases involving serious brain injuries or tumors have surpassed $3 million.
Factors that may affect the value of a claim include:
Whether the meningioma required surgery, radiation, or other intensive treatment
Permanent neurological, cognitive, sensory, or mobility impairments
Recurring, residual, inoperable, or higher-grade tumors
Past and future medical expenses
Lost wages and reduced earning capacity
The number and duration of injectable contraceptive doses
The strength of the evidence connecting Depo-Provera use to the diagnosis
The increased risk of future complications or continued medical monitoring
High-severity claims involving multiple procedures, permanent disability, or substantial future care needs may receive settlements exceeding $1 million.
These figures are projections rather than confirmed payment amounts, and the value of each claim will depend on its individual medical evidence, damages, and eligibility requirements.
If you believe Depo Provera caused an intracranial or spinal meningioma, TorHoerman Law can review your injection history, diagnosis, treatment, and available medical records.
Our attorneys can determine whether the facts support a Depo Provera shot lawsuit and explain how the federal litigation and settlement process may affect your claim.
We offer free, no-obligation consultations and can help obtain missing injection, insurance, imaging, surgical, and treatment records.
You can also use the chat feature on this page to complete a preliminary case review.
Submitting your information does not automatically file a lawsuit or confirm eligibility. Representation begins only after TorHoerman Law accepts the case and an attorney-client agreement is signed.
Gathering Evidence for the Depo-Provera Brain Tumor Lawsuit
Building a strong Depo-Provera brain tumor lawsuit starts with thorough and accurate evidence collection.
Evidence helps demonstrate the link between prolonged Depo-Provera use and brain tumor diagnoses.
Our attorneys will help you gather and retain critical evidence to bolster your case and improve your chances of obtaining fair compensation.
Evidence in a Depo-Provera lawsuit may include:
Medical records confirming Depo-Provera injections and the duration of use
Diagnostic reports confirming a brain tumor diagnosis, including imaging results (MRIs, CT scans)
Prescription and pharmacy records showing the history of Depo-Provera usage
Documentation of medical treatments and related expenses (surgery, radiation, medications)
Statements from healthcare providers regarding the potential link between Depo-Provera and the brain tumor
Employment records detailing lost wages or diminished earning capacity
Personal statements and testimony detailing physical, emotional, and financial impacts caused by the tumor
Damages in Depo-Provera Lawsuits
Damages in a lawsuit refer to the financial compensation sought by individuals who have suffered harm due to another party’s negligence or wrongdoing.
In a Depo-Provera lawsuit, damages aim to cover the medical expenses, emotional suffering, and other losses experienced by victims.
TorHoerman Law represents individuals who developed an intracranial or spinal meningioma after the use of Depo Provera.
Our attorneys review injection records, diagnostic imaging, surgical reports, treatment history, lost income, and other evidence needed to evaluate a potential claim involving dangerous drugs.
We manage the legal process from the initial case review through record collection, court filings, MDL requirements, and potential settlement proceedings.
Clients receive updates about significant developments and may be asked to provide additional information or sign medical-record authorizations as the claim moves forward.
If you or a loved one received Depo-Provera injections and were later diagnosed with a meningioma, contact TorHoerman Law for a free, confidential consultation.
You pay no upfront legal fees, and our firm receives a fee only if compensation is recovered for your claim.
You may still be able to file a claim even if you do not currently have your Depo-Provera injection records.
Attorneys may use medical records, pharmacy histories, insurance claims, billing statements, or records from the clinic that administered depot medroxyprogesterone acetate to prove Depo Provera exposure.
Depo-Provera contains a synthetic form of the hormone progesterone, so older records may identify the medication by its generic name rather than the brand name.
A law firm may help request missing documentation after receiving your authorization, but the available evidence must still confirm the product used and the approximate dates or number of injections.
You may still qualify for a Depo-Provera lawsuit if your meningioma is benign.
Most meningiomas are noncancerous, but they can still press against the brain, spinal cord, nerves, or blood vessels and cause serious neurological symptoms.
A benign tumor may require surgery, radiation, ongoing imaging, medication, or long-term specialist care.
Eligibility depends on your Depo-Provera injection history, diagnosis, treatment, medical records, and applicable filing deadline rather than whether the tumor is cancerous.
You may still qualify if you received a generic equivalent of Depo-Provera and were later diagnosed with a meningioma.
The federal MDL includes claims involving Depo-Provera and generic injectable medroxyprogesterone acetate products, and the named defendants include Prasco, Greenstone, and Viatris.
Eligibility may depend on identifying the specific product, manufacturer, injection dates, diagnosis, and applicable filing deadline.
Medical, insurance, pharmacy, or clinic records may help determine which version you received.
Surgery is not necessarily required to file a Depo-Provera lawsuit.
A claimant may still qualify if the meningioma is inoperable, managed through regular imaging, treated with radiation, or causes neurological symptoms without surgical removal.
Attorneys will review the tumor’s location, size, symptoms, treatment plan, injection history, medical records, and effect on daily life.
Surgery may increase the value of a claim, but eligibility depends on the full medical and factual record.
You may still request a case review if you do not remember the exact number or dates of your Depo-Provera injections.
Medical records, insurance claims, pharmacy histories, billing statements, and records from the clinic that administered the medication may help establish your injection history.
Attorneys can use these documents to determine whether you received at least two injections and whether your exposure meets the current preliminary criteria.
You do not need to locate every record before contacting a law firm.
Tor Hoerman has represented injured individuals for more than 30 years, with experience spanning individual personal injury cases and nationwide mass tort litigation. His work includes car accidents, catastrophic injuries, product liability claims, and other serious injury cases. Tor has served in court-appointed leadership roles in national litigation and tried cases involving major corporate defendants.
Legally Reviewed
TorHoerman Law’s legal content is researched and written by our editorial team and attorneys for legal accuracy, clarity, and relevance. We rely on statutes, court records, government publications, medical research, and other authoritative sources when applicable. This page provides general legal information and does not constitute legal advice.
Fact-Checked
TorHoerman Law reviews its legal content for factual accuracy, current information, and relevant legal context before publication and as material developments occur. This article is provided for general informational purposes and does not constitute legal advice. For guidance about a specific case, contact TorHoerman Law.
Additional Depo-Provera Lawsuit resources on our website:
You received at least 2 Depo-Provera injections after 1992 and were diagnosed with intracranial meningioma confirmed by imaging (MRI or CT scan).
You used Depo-Provera for over one year.
You had no brain tumor history before Depo-Provera use, and medical records show the tumor developed after starting injections (even if diagnosed months or years later).
Most Recent Updates
Our Depo-Provera Lawyers are accepting new clients for this lawsuit.
TorHoerman Law represents people whose lives have been disrupted by serious injuries, unsafe products, and negligence. Our attorneys handle individual personal injury cases as well as national mass tort lawsuits involving major corporations.
Founded in 2009, our legal team brings more than 100 years of combined experience handling serious injury and complex civil litigation.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
In this case, we obtained a verdict of $495 Million for our client’s child who was diagnosed with Necrotizing Enterocolitis after consuming baby formula manufactured by Abbott Laboratories.
